Hepatitis D cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) (Created page with "__NOTOC__ {{Hepatitis B}} {{CMG}}; ==Overview== ==References== {{Reflist|2}} D Category:Viruses Category:Infectious disease Category:Gast...") |
m (Bot: Removing from Primary care) |
||
| (6 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hepatitis | {{Hepatitis D}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Considering that patients who develop [[symptomatic]] [[hepatitis D]] may progress into [[cirrhosis]], [[liver failure]] and [[hepatocellular carcinoma]], research for an adequate therapeutic regimen and for new and more effective drugs, with less side-effects, and lower costs may be considered cost-effective. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Hepatitis|D]] | [[Category:Hepatitis|D]] | ||
[[Category:Viruses]] | [[Category:Viruses]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Hepatology]] | |||
Latest revision as of 22:06, 29 July 2020
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Hepatitis D cost-effectiveness of therapy |
|
Risk calculators and risk factors for Hepatitis D cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Considering that patients who develop symptomatic hepatitis D may progress into cirrhosis, liver failure and hepatocellular carcinoma, research for an adequate therapeutic regimen and for new and more effective drugs, with less side-effects, and lower costs may be considered cost-effective.